AETHLON MEDICAL INC (AEMD) Form 8-K — Jul 8, 2026
Aethlon Medical, Inc. closed its registered public offering on July 7, 2026, raising approximately $4.0 million in gross proceeds. The offering consisted of 263,000 shares of common stock, 5,633,009 common warrants, and 5,370,009 pre-funded warrants, sold at a combined public offering price of $0.71 per share and accompanying warrant. Maxim Group LLC acted as the placement agent on a reasonable best efforts basis and received a cash fee of 6.25% of the aggregate gross proceeds, amounting to $260,000, plus reimbursement for expenses.
Key figures
- Gross Proceeds
- $4,000,000
- Offering Price
- $0.71
- Shares Offered
- 263000
- Net Proceeds
- $3,335,000
- Common Warrants
- 5633009
- Placement Agent Fee
- $260,000
- Pre Funded Warrants
- 5370009
- Placement Agent Warrants
- 225320
Price after filing
Close on the filing date to close N calendar days later (from $3.65). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.